Botanical species · safety record

Myrica gale

The EFSA Compendium of Botanicals holds 6 constituent measurements and 2 adverse-effect records for Myrica gale. This page reports what those source records contain and how to reach them. It carries no effect estimate, no dose and no recommendation.

Accepted name in source: Myrica gale L.

6Constituent measurements

2Safety records

5Cited sources

0Licensed products (Canada)

Also recorded as

Myrica gale var. tomentosa C. DC.

Synonyms are carried from the source compendium. A species may be traded and studied under more than one name, which is exactly how a safety record gets lost.

Regulatory presence

No Health Canada licensed natural health product in the snapshot names this species as a medicinal ingredient under this exact binomial. Absence here means absence from this one register under this one name, not absence from trade, and not a safety verdict.

What the records describe

Constituents measured

Plant parts

Preparations

Effect types

Target tissues

Recorded constituents

What analytical work has found in this species, at which plant part and preparation. A measured constituent is a fact about material, not about effect.

Substance	Plant part	Preparation	Concentration	Analytical method	Source
1,8-cineole	Fruit unspecified	Solvent extraction	≥ 20.2 Percent	GC-MS	No resolvable identifier
1,8-cineole	Fruit unspecified	Solvent extraction	≤ 28 Percent	GC-MS	No resolvable identifier
Gallic acid	Stem / stalk	Solvent extraction	—	Nuclear Magnetic Resonance (NMR)	No resolvable identifier
Lignans	Live plants	Solvent extraction	—	Unspecified	No resolvable identifier
Myrcene	Leaves	Essential oil	≥ 7.7 Percent	GC-MS	No resolvable identifier
Myrcene	Leaves	Essential oil	≤ 20.4 Percent	GC-MS	No resolvable identifier

Recorded adverse effects

Adverse effects reported in the source literature, most often in animal or laboratory models at a stated preparation and dose.

Effect	Target tissue	Plant part	Preparation	Test organism	Test type	Source
Digestive	Digestive	Live plants	Resin (as part-nature)	Dog (as animal)	Case report	No resolvable identifier
Reproductive	Uterus	Live plants	Resin (as part-nature)	Dog (as animal)	Case report	No resolvable identifier

Cited sources

The literature the compendium cites for this species. Metatron Health has no relationship with these authors or journals and earns nothing from citing them.

Wishart, DS., Jewison, T., Guo, AC., Wilson, M., Knox, C., Liu, Y., Djoumbou, Y., Mandal, R., Aziat, F., Dong, E., Bouatra, S., Sinelnikov, I., Arndt, D., Xia, J., Liu, P., Yallou, F., Bjorndahl, T., Perez-Pineiro, R., Eisner, R., Allen, F., Neveu, V., Greiner, R., Scalbert, A. (+)-Galeon (HMDB31534).. human metabolome database, 2012, vol. 3.0.
Chevalier, J. The Pharmacodynamic and Toxic Action of Myrica gale L. and of the Essence which it Contains. Comptes rendus des seances de la societe de biologie et de ses filiales, 1910, p. 738-740.
Sokolova, M., Orav, A., Koel, M., Kailas, T., Muurisepp, M. Composition of the oil and supercritical fluid CO2 extract of sweet gale (Myrica gale L.) fruits . Journal of essential oil research, 2005, vol. 17, no. 2, p. 188-191.
NAGAI, M., DOHI, J., MORIHARA, M., SAKURAI, N. DIARYLHEPTANOIDS FROM MYRICA-GALE VAR TOMENTOSA AND REVISED STRUCTURE OF PORSON . Chemical & pharmaceutical bulletin, 1995, vol. 43, no. 10, p. 1674-1677.
B�langer, A., Dextraze, L., Isnardi, M.J., Chalchat, J.C., Garry, R.Ph., Collin, G. Chemical Composition of Essential Oil and Headspace of the Quebec Myrique baumier Wax Myrtle (Myrica gale L.). Influence of Extraction Process. Journal of essential oil research, 1997, vol. 9, no. 6, p. 657-662.

Boundary

A constituent measurement is a fact about material at a stated preparation, not a statement about what that material does in a person. An adverse-effect or genotoxicity record is an observation reported in a source, most often in an animal or laboratory model. Neither is a Metatron Health conclusion about causality, human risk or benefit, and the absence of a record is not proof that a preparation is safe. Nothing here is diagnosis, prescribing or individual medical care.

Continue

Independent literature